Thermo Fisher Scientific Inc. (NYSE:TMO) surpassed analyst expectations for the fourth quarter of 2024, reporting higher-than-anticipated earnings per share (EPS) and revenue. The company's stock rose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback